Best Buy Slides amid Weak Sales Outlook

Citigroup finishes higher on Brazil bailout deal; Schering-Plough to appeal patent ruling; plus more stocks in the news

Schering-Plough (SGP ) disagreed with and will appeal a U.S. District Court ruling which found certain claims of patent protecting against generic versions of Claritin, expiring in 2004, are not valid.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.